{"image_url":null,"blog_title":"\u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a","height":"190","published":"2023-08-13 20:59:15","title":"EGPA\u3078\u306eBenralizumab","author_url":"https://blog.hatena.ne.jp/CTD_GIM/","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fctd-gim.hatenablog.com%2Fentry%2F2023%2F08%2F13%2F205915\" title=\"EGPA\u3078\u306eBenralizumab - \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","categories":["ANCA\u95a2\u9023\u8840\u7ba1\u708e","\u6cbb\u7642\u85ac"],"width":"100%","url":"https://ctd-gim.hatenablog.com/entry/2023/08/13/205915","type":"rich","provider_name":"Hatena Blog","author_name":"CTD_GIM","version":"1.0","provider_url":"https://hatena.blog","blog_url":"https://ctd-gim.hatenablog.com/","description":"Benralizumab for eosinophilic granulomatosis with polyangiitis [published online ahead of print, 2023 Aug 7]. Ann Rheum Dis. 2023;ard-2023-224624. doi:10.1136/ard-2023-224624 Benralizumab\uff08\u30d5\u30a1\u30bb\u30f3\u30e9\u00ae\uff09\u306f\u3001\u597d\u9178\u7403\u9664\u53bb\u80fd\u529b\u304c\u975e\u5e38\u306b\u9ad8\u3044IL-5\u03b1\u53d7\u5bb9\u4f53\u6297\u4f53\u3067\u3001\u6c17\u7ba1\u652f\u5598\u606f\u306b\u306e\u307f\u65e5\u672c\u3067\u306f\u4fdd\u967a\u9069\u7528\u304c\u3042\u308b\u3002 \u8840\u7ba1\u708e\u306e\u63a8\u5968\u3067\u306f\u597d\u9178\u7403\u6027\u591a\u767a\u8840\u7ba1\u708e\u6027\u8089\u82bd\u816b\u75c7\uff08EGPA\uff09\u3078\u306eIL-5\u6297\u4f53\u3068\u3057\u3066\u306fMepolizumab\u306e\u307f\u63a8\u5968\u304c\u3042\u2026"}